Yondelis 1 mg powder for concentrate for solution for infusion, DOXORUBICINE ARROW 2 mg/ml, solution pour perfusion
UC-SAR-2212_L-UteCIN
Phase 2 small_molecule active
Quick answer
Yondelis 1 mg powder for concentrate for solution for infusion, DOXORUBICINE ARROW 2 mg/ml, solution pour perfusion for Localized, resected, FIGO stage I (2018 classification), uterine leiomyosarcoma is a Phase 2 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Localized, resected, FIGO stage I (2018 classification), uterine leiomyosarcoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active